Severe adrenal insufficiency in six neonates with normal newborn screening for CAH

Authors

İlknur Kurt•Metin Eser•Tülay Güran

Published

May 26, 2024

Abstract

Newborn screening (NBS) reduces the risk of mortality in congenital adrenal hyperplasia (CAH), mainly due to the salt-wasting form of 21-hydroxylase deficiency. There is limited knowledge regarding the results of NBS in non-CAH primary adrenal insufficiency (non-CAH PAI).